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The type II clustered regularly interspaced short palindromic repeats
(CRISPR)/CRISPR-associated (Cas) system has emerged recently as
a powerful method to manipulate the genomes of various organ-
isms. Here, we report a toolbox for high-efficiency genome engi-
neering of Drosophila melanogaster consisting of transgenic Cas9
lines and versatile guide RNA (gRNA) expression plasmids. Sys-
tematic evaluation reveals Cas9 lines with ubiquitous or germ-
line–restricted patterns of activity. We also demonstrate differential
activity of the same gRNA expressed from different U6 snRNA pro-
moters, with the previously untested U6:3 promoter giving themost
potent effect. An appropriate combination of Cas9 and gRNA allows
targeting of essential and nonessential genes with transmission rates
ranging from 25–100%. We also demonstrate that our optimized
CRISPR/Cas tools can be used for offset nicking-based mutagenesis.
Furthermore, in combination with oligonucleotide or long double-
stranded donor templates, our reagents allow precise genome edit-
ing by homology-directed repair with rates that make selection
markers unnecessary. Last, we demonstrate a novel application of
CRISPR/Cas-mediated technology in revealing loss-of-function phe-
notypes in somatic cells following efficient biallelic targeting by
Cas9 expressed in a ubiquitous or tissue-restricted manner. Our
CRISPR/Cas tools will facilitate the rapid evaluation of mutant phe-
notypes of specific genes and the precise modification of the ge-
nome with single-nucleotide precision. Our results also pave the
way for high-throughput genetic screening with CRISPR/Cas.
Experimentally induced mutations in the genomes of modelorganisms have been the basis of much of our current
understanding of biological mechanisms. However, traditional
mutagenesis tools have significant drawbacks. Forward genetic
approaches such as chemical mutagenesis lack specificity, lead-
ing to unwanted mutations at many sites in the genome. Tradi-
tional reverse genetic approaches, such as gene targeting by
conventional homologous recombination, suffer from low effi-
ciency and therefore are labor intensive. In recent years novel
methods have been developed that aim to modify genomes with
high precision and high efficiency by introducing double-stand
breaks (DSBs) at defined loci (1). DSBs can be repaired by ei-
ther nonhomologous end joining (NHEJ) or homology-directed
repair (HDR). NHEJ is an error-prone process that frequently
leads to the generation of small, mutagenic insertions and
deletions (indels). HDR repairs DSBs by precisely copying se-
quence from a donor template, allowing specific changes to be
introduced into the genome (2).
The type II clustered regular interspersed short palindromic
repeat (CRISPR)/CRISPR-associated (Cas) system has emerged
recently as an extraordinarily powerful method for inducing site-
specific DSBs in the genomes of a variety of organisms. The
method exploits the RNA-guided endonuclease Cas9, which plays
a key role in bacterial adaptive immune systems. Target specificity
of Cas9 is encoded by a 20-nt spacer sequence in the crisprRNA,
which pairs with the transactivating RNA to direct the endonu-
clease to the complementary target site in the DNA (3). For
genome engineering, crisprRNA and transactivating RNA can be
combined in a single chimeric guide RNA (gRNA), resulting in
a simple two-component system for the creation of DSBs at
defined sites (3). Binding of the Cas9/gRNA complex at a genomic
target site is constrained only by the requirement for an adjacent
short protospacer-adjacent motif (PAM), which for the commonly
used Streptococcus pyogenes Cas9 is NGG (4).
Several groups recently demonstrated CRISPR/Cas-mediated
editing of the genome of Drosophila melanogaster (5–12), a key
model organism for biological research. However, the rate of
mutagenesis has varied widely both within and among different
studies. Differences in the methods used to introduce Cas9 and
gRNAs into the fly likely contribute significantly to different
experimental outcomes. Kondo and Ueda (8) expressed both
Cas9 and gRNA from transgenes stably integrated into the ge-
nome, but all other studies have used microinjection of expres-
sion plasmids or of in vitro-transcribed RNA into embryos to
deliver one or both CRISPR/Cas components (5–7, 9–11). Much
of the currently available evidence suggests that transgenic
provision of Cas9 increases rates of germ-line transmission
substantially (8, 10, 11). However, the influence of different
regulatory sequences within cas9 transgenes on the rate of mu-
tagenesis and on the location where mutations are generated
within the organism has not been evaluated. The effect of dif-
ferent promoter sequences on the activities of gRNAs also has
not been explored systematically. Therefore it is possible that
suboptimal tools are being used currently for many CRISPR/Cas
experiments in Drosophila.
Previous studies in Drosophila have focused on the use of
CRISPR/Cas to create heritable mutations in the germ line. In
principle, efficient biallelic targeting within somatic cells of
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Drosophila would represent a powerful system to dissect the func-
tions of genes within an organismal context. However, the feasibility
of such an approach has not been explored so far.
Here, we present a versatile CRISPR/Cas toolbox for Drosophila
genome engineering consisting of a set of systematically evaluated
transgenic Cas9 lines and gRNA-expression plasmids. We describe
combinations of Cas9 and gRNA sources that can be used to in-
duce, with high efficiency, loss-of-function mutations in nonessential
or essential genes and integration of designer sequences by HDR.
Finally, we show that our optimized transgenic tools permit efficient
biallelic targeting in a variety of somatic tissues of the fly, allowing
the characterization of mutant phenotypes directly in Cas9/gRNA-
expressing animals.
Results
Generation and Evaluation of Cas9 Transgenes. We generated a se-
ries of Cas9-expressing transgenes (Table S1) to compare their
expression patterns and endonuclease activities. Expression plas-
mids were produced encoding S. pyogenes Cas9 [codon optimized
for expression in human (13, 14) or Drosophila cells] fused to
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Fig. 1. Systematic evaluation of transgenic Cas9 strains. (A) Schematic of sequence and position of gRNA-e and gRNA-y target sites in the e and y loci. UTRs are
shown in gray, and coding sequences are shown as colored blocks. Cas9 cut sites are indicated by arrowheads. (B and C) Representative examples of female flies
expressing one copy of the different cas9 transgenes and one copy of the U6:3-gRNA-e (B) or U6:3-gRNA-y (C) transgene compared with wild-type controls (at
least 200 adults of each genotype were examined). Body coloration darker (B) or lighter (C) than the control indicates CRISPR/Cas-mediated mutagenesis of the
target gene in epidermal cells. The number of wild-type alleles present in each animal that must be mutated to give rise to the mutant phenotype is indicated
below each image. Somatic targeting is widespread in animals expressing act-cas9 or vasa-cas9, is sporadic in animals expressing nos-cas9:GFP and nosG4VP16
UAS-cas9 (arrowheads), and is undetectable in animals expressing nos-cas9. (D and E) Assessment of germ-line transmission of nonfunctional e (D) and y (E)
alleles induced by different cas9 transgenes, performed by crossing animals expressing cas9 and the appropriate gRNA to e or ymutant animals. Data represent
mean and SEM from at least eight (D) or four (E) independent crosses for each cas9 line. Efficient germ-line transmission of CRISPR/Cas-induced mutations was
observed for all cas9 transgenes, although statistically significant differences in mean values were apparent (*P < 0.05; **P < 0.01; ***P < 0.001; unpaired t test
compared with act-cas9with the same gRNA). Displayed values for U6:3-gRNA-y experiments are normalized to account for the 25% of ymutant offspring that
would be expected in some crosses in the absence of CRISPR/Cas-mediated mutagenesis (Table S3). (F) Examples of sequences of CRISPR/Cas-induced germ-line
mutations in e and y (found in the offspring of act-cas9 gRNA flies). Somemutations were observed in several different flies. The in-framemutation in e (bottom
sequence) was obtained from a fly with wild-type pigmentation. The start codon in this and subsequent figures is shown in bold text.
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nuclear localization signals under the control of different regu-
latory sequences. We generated two constructs in which Cas9
was under the control of the nos promoter, which is active in
the male and female germ line (15), and the nos 3′ UTR, which
targets protein synthesis to the germ cells (15). These constructs
are similar to those used by two previous studies to provide Cas9
transgenically (8, 10). We also generated two novel constructs:
(i) act-cas9, in which Cas9 is fused to the ubiquitously expressed
actin5C (act) promoter and the SV40 3′ UTR, and (ii) UAS-
cas9, which has yeast upstream-activating sequences (UAS),
allowing expression under control of the Gal4 transcriptional
activator (16), and the p10 3′ UTR, which promotes efficient
translation (17). These plasmids were integrated into the Dro-
sophila genome at defined positions using the attB/attP/Phi31C
system (18, 19). We also obtained two published stocks that
express, from different genomic locations, a cas9 transgene un-
der control of the vasa promoter and 3′ UTR that is purported to
restrict expression of the endonuclease to the germ line (11).
To test the different Cas9 lines functionally, we designed a
gRNA targeting the ebony (e) gene on chromosome 3 (referred
to as “gRNA-e”) (Fig. 1A). Mutation of both wild-type e alleles
leads to very dark coloration of the adult cuticle. gRNA-e targets
Cas9 to the 5′ end of the e coding sequence, 25 bp after the
translation initiation codon. A construct expressing gRNA-e
from the promoter of the U6:3 spliceosomal snRNA gene (see
below) was integrated stably at the attP2 site on chromosome 3
(Table S2). Transgenic supply of the gRNA was designed to
eliminate the variability between experiments that is associated
with direct injection of a plasmid or in vitro-transcribed RNA
into embryos, thereby facilitating meaningful comparison of the
activities of the different Cas9 lines.
Flies expressing the U6:3-gRNA-e transgene were crossed to
the transgenic Cas9 lines (see Fig. S1 for the general crossing
scheme). Remarkably, all adult offspring expressing gRNA-e and
act-cas9 had mosaic pigmentation in which the majority of cuticle
exhibited very dark coloration (Fig. 1B). This result demon-
strates highly efficient biallelic targeting of e in somatic cells.
Surprisingly, the two independent genomic insertions of vasa-
cas9 in combination with gRNA-e also resulted in e mutant tissue
throughout most of the cuticle (Fig. 1B). Thus, Cas9 activity is
not restricted to the germ line by either vasa-cas9 transgene. All
nos-cas9:GFP U6:3-gRNA-e flies had patches of dark cuticle,
but these patches were relatively small and infrequent (Fig. 1B).
A similar phenotype was observed in ∼40% of flies in which
U6:3-gRNA-e was combined with UAS-cas9 driven by the strong
transcriptional activator Gal4VP16 under the control of nos
regulatory sequences (nosG4VP16) (Fig. 1B). In contrast, all nos-
cas9 U6:3-gRNA-e flies had wild-type coloration of the entire
cuticle (Fig. 1B). The differential activity of nos-cas9:GFP and
nos-cas9—both of which use the same nos promoter and 3′
UTR sequences and are inserted at the same genomic location—
presumably reflects an influence of the GFP moiety, number of
nuclear localization signals, or differences in the codon use for
the Cas9 ORF in each construct (Table S1).
We next compared the somatic activity of the cas9 transgenes
using a second gRNA transgene, which targets the X-linked
yellow (y) gene 94 bp after the start codon (referred to as “gRNA-y”)
(Fig. 1A). This gRNA also was expressed from the U6:3 pro-
moter and was stably integrated at the attP2 site. In the absence
of a wild-type y allele, the adult cuticle has lighter, yellow pig-
mentation. The combination of U6:3-gRNA-y with act-cas9 or
vasa-cas9 led to a predominantly yellow cuticle in all animals
(Fig. 1C). This was even the case in a vasa-cas9 U6:3-gRNA-y
genotype in which four wild-type y alleles had to be mutated
to give the yellow phenotype (Fig. 1C); note that different crosses
had different numbers of y+ alleles because of differences
in the genotypes of the Cas9 parental strains (Fig. 1C, Table
S3, and Materials and Methods). In contrast, nos-cas9:GFP
U6:3-gRNA-y animals had cuticle that contained only small
clones of y mutant tissue (Fig. 1C), whereas the combination
of U6:3-gRNA-y with nosG4VP16 > UAS-cas9 or nos-cas9 resulted
in phenotypically wild-type cuticle throughout the animal (Fig. 1C).
nos-cas9 U6:3-gRNA-ymales, in which only a single wild-type y allele
had to be mutated to produce yellow cuticle, also had wild-type
pigmentation throughout the animal (Fig. S2). Together, the
experiments with gRNA-e and gRNA-y demonstrate that act-
cas9 and vasa-cas9 have substantial activity in cells that give
rise to the cuticle, but activity in these cells is relatively low
in nos-cas9:GFP and nosG4VP16 > UAS-cas9 flies and is not
detectable in nos-cas9 flies.
We next assessed the germ-line transmission of CRISPR/Cas-
induced mutations in e and y (Fig. 1 D and E and Table S4).
Individual flies containing each cas9 transgene and U6:3-gRNA-
e were crossed to a classical e mutant strain. All cas9 transgenes
resulted in 42–54% of transmitted e alleles being nonfunctional
(mean values from at least eight crosses per transgene) with the
exception of nos-cas9, for which the mean value was 26 ± 3%
(Fig. 1D and Table S4). Sequencing of nonfunctional e alleles
from one of these crosses revealed a range of small indels in the
vicinity of the predicted Cas9 cleavage site (Fig. 1F); this finding
is consistent with molecular analysis of CRISPR/Cas-induced
alleles in other studies (5–8, 10).
We assessed the transmission of CRISPR/Cas-induced
y mutant alleles by crossing flies containing U6:3-gRNA-y and the
different cas9 transgenes to a strain with a classical ymutant allele.
In all cases, an average of >70% of the progeny expected to have
wild-type pigmentation in the absence of mutagenesis had phe-
notypically yellow cuticle (Fig. 1E and Table S4). In the case of
the act-cas9 and one of the vasa-cas9 transgenes, an average of
99–100% of such progeny were yellow (Fig. 1E and Table S4),
demonstrating CRISPR/Cas-induced mutagenesis of wild-type
y alleles in almost every germ cell. As expected, sequencing
analysis of the progeny revealed indels at the predicted location
of the y locus (Fig. 1F). Collectively our experiments indicate
that act-cas9 and vasa-cas9 transgenes can induce mutations in
somatic and germ-line cells with high frequencies and that nos-
cas9 allows efficient germ-line transmission of mutations without
widespread targeting in somatic cells.
It was intriguing that for each cas9 transgene the frequency
of transmission of nonfunctional y alleles was higher than that
observed for e alleles (Fig. 1 D and E). To determine whether the
ability of e to tolerate in-frame mutations at the gRNA-e target
site contributes to this difference, the target site of eight phe-
notypically wild-type progeny from act-cas9 U6:3-gRNA-e parents
was sequenced. Seven flies had small indels that retain the
overall reading frame (e.g., Fig. 1F); only a single fly inherited an
unmodified e locus. Thus, the frequency of nucleotide changes in
gRNA-e experiments is substantially higher than suggested by
phenotypic screening.
Optimized Single and Double gRNA Expression Vectors. To date,
gRNAs targeting the Drosophila genome have been transcribed
from one of the RNA polymerase III-dependent promoters
of the U6 snRNA genes (5, 9–11). There are three U6 genes in
the fly: U6:1, U6:2, and U6:3. The great majority of published
CRISPR/Cas experiments have used gRNAs produced by the
U6:2 promoter. The U6:1 promoter has been assessed in a
single experiment using direct plasmid injection to deliver the
gRNA construct (10), and the U6:3 promoter has not been
used previously. To compare the activity of the three U6 pro-
moters in CRISPR/Cas experiments, plasmids were generated
harboring each U6 promoter followed by the gRNA core
sequence and a BbsI restriction-site cassette (Fig. 2A and
Fig. S3). The plasmids also contained an attB site to allow
integration at defined positions in the Drosophila genome and
an eye pigmentation marker to permit screening for insertion
Port et al. PNAS | Published online July 7, 2014 | E2969
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events. We used these plasmids to generate constructs expressing
gRNA-y under the control of each U6 promoter. To avoid posi-
tional effects on gRNA expression, each construct was stably
integrated at the attP40 site on chromosome 2.
Flies expressing each gRNA-y transgene were crossed to flies
expressing the act-cas9 transgene. All progeny expressing act-
cas9 and U6:3-gRNA-y developed a completely yellow cuticle
(Fig. 2B). This finding indicates extremely efficient targeting
of the two wild-type y alleles in this cross, consistent with results
of combining this cas9 transgene with U6:3-gRNA-y integrated at
another genomic site (Fig. 1C). All act-cas9 U6:1-gRNA-y ani-
mals developed cuticle that was mostly yellow but had small
spots of wild-type tissue (Fig. 2B). In contrast, all act-cas9
U6:2-gRNA-y flies retained large amounts of wild-type cuticle
with many small yellow patches (Fig. 2B). We also produced flies
expressing nos-cas9 and each of the U6-gRNA-y constructs and
assessed the germ-line transmission of nonfunctional y alleles to
the next generation as described above. Of the progeny expected
to have wild-type pigmentation in the absence of CRISPR/
Cas-mediated targeting, 69 ± 2%, 41 ± 3%, and 99 ± 1%
were phenotypically yellow when the U6:1, U6:2 and U6:3 pro-
moters were used, respectively (Fig. 2C and Table S4). Col-
lectively, these results demonstrate that the different U6
promoters differ substantially in their ability of drive muta-
genesis in both somatic cells and the germ line, with U6:3
having the strongest, U6:2 having the weakest, and U6:1 having
intermediate activity.
Simultaneous expression of two gRNAs can be used to create
defined deletions (5, 8), to target two genes simultaneously (20),
or to mutagenize a single gene by offset nicking (21, 22). The last
method increases CRISPR/Cas specificity by combining a Cas9
“nickase”mutant [Cas9D10A (3)], which cuts only one DNA strand,
with two gRNAs to the target gene. DSBs are induced by this
protein only when two molecules are guided to opposite strands
of the DNA in close proximity, an event that is extremely un-
likely at an off-target site. This method has not been used pre-
viously in Drosophila. To enable simultaneous expression of two
gRNAs, we produced a plasmid containing both the U6:1 and
U6:3 promoters adjacent to gRNA core sequences (Fig. 2D).
Different promoters were chosen to avoid the risk associated
with recombination between identical sequences during cloning
exercises. The plasmid was designed to allow one-step cloning of
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Fig. 2. Versatile gRNA-expression vectors. (A) Schematic of the U6 locus. U6 genes are shown as orange blocks; intervening sequences and neighboring genes
are shown in gray. Sequences 5′ to each U6 gene were cloned in front of a core gRNA sequence to generate plasmids pCFD1–3. The asterisk indicates positions
of the BbsI cloning cassette for insertion of target sequence. (B) Differential activity of U6-gRNA constructs in epidermal cells. Female flies are shown that are
heterozygous for act-cas9 and a gRNA-y transgene under the control of the U6:1, U6:2, or U6:3 promoter. Lighter body coloration indicates CRISPR/Cas-
mediated mutagenesis of the two wild-type y alleles present in these flies. Arrowheads show examples of wild-type pigmentation with the U6:1 promoter and
mutant pigmentation with the U6:2 promoter. (C) Mean germ-line transmission rates using different gRNA transgenes. nos-cas9 U6-gRNA-y females were
crossed to y mutant males, and y mutant offspring were counted (three crosses per genotype). Displayed values are adjusted to account for the 25% of
y mutant offspring expected in the absence of mutagenesis. Error bars represent SEM. (D) Targeting of two genes in the same animal with a double gRNA
vector, pCFD4. Representative images are shown of flies that express act-cas9 in the absence or presence of a single transgene expressing gRNAs to e and cu.
The arrowhead indicates the curled wing of a fly with extensive ebony pigmentation. (E) pCFD4 allows mutagenesis by offset-nicking in combination with act-
cas9D10A. (Upper Left) Target sites of gRNAs (arrowheads indicate location of nicks). (Right) Summary of results from injecting pCFD4 encoding the two y
gRNAs into transgenic act-cas9D10A embryos and crossing to y flies to assess germ-line transmission of loss-of-function y alleles. In these and other figures,
“founder” refers to an animal that transmitted mutant alleles to the next generation. In the four crosses, 22 of 22 files, 11 of 56 flies, 27 of 31 files, and none
of 35 flies inherited a nonfunctional y allele. (Lower Left) Sequence of six different indels found in 20 analyzed yellow progeny.
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the two gRNAs by introducing target sequences in PCR primers
(Fig. S3) and therefore allows more convenient and rapid work-
flow than a previously reported strategy for the same task, which
used sequential cloning of gRNAs adjacent to two U6:2 pro-
moters (8).
We used our dual gRNA plasmid to make a transgenic line
simultaneously expressing gRNAs targeting e or curled (cu), which
causes a curled wing phenotype when mutated (23), and crossing
that line to act-cas9 flies. All 120 of the analyzed act-cas9 gRNA-e
gRNA-cu flies had large patches of dark cuticle, and 52% had
one or two curled wings (Fig. 2D). Thus, the dual gRNA plasmid
can be used to target two genes in the same animal efficiently.
We also integrated two sequences targeting opposite strands
of the y locus into the dual gRNA vector and injected the plasmid
directly into transgenic embryos expressing the Cas9D10A nickase
under the control of the act promoter (Table S1). Forty-two
percent of the offspring from injected animals received a non-
functional y allele, which we confirmed was associated with
indels at the expected position (Fig. 2E). All transgenic animals
expressing both act-cas9D10A and the strong single-target U6:3-
gRNA-y transgene had wild-type coloration of the cuticle, in-
dicating that single DNA nicks have low mutagenic potential
in flies. We conclude that the dual gRNA vector can be used in
combination with act-cas9D10A flies to create mutagenic DSBs
through offset nicking.
Efficient Germ-Line Transmission of Mutations in Essential Genes. The
experiments described above identified Cas9 and gRNA reagents
that can target nonessential genes in somatic and/or germ-line
tissues with different efficiencies. We next sought to identify Cas9/
gRNA combinations that can give efficient germ-line transmission
of mutations in genes that are essential for viability. Doing so
necessitates finding conditions in which transmission is not
compromised by deleterious effects of biallelic gene targeting in
somatic tissues. We generated transgenic fly lines expressing
gRNAs targeting the genes encoding either the secreted signal-
ing molecule Wingless (Wg) or the Wg secretion factor Wntless
(Wls). Both the wg and wls genes are essential in the soma for
development of Drosophila to adult stages (24–26). Both gRNAs
were under the control of the U6:3 promoter and integrated at
the attP40 site. gRNA-wg directs Cas9 to cut just after the region
of the target gene that encodes the signal sequence, and gRNA-
wls directs Cas9 to cut within the signal sequence-encoding re-
gion of the target gene (Fig. 3A).
No offspring survived past the pupal stage when U6:3-gRNA-wg
or U6:3-gRNA-wls flies were crossed to the ubiquitous act-cas9
line (Fig. 3B), presumably because of effective biallelic targeting
of wg and wls in the soma. Crossing vasa-cas9, nos-cas9:GFP, and
nosG4VP16 > UAS-cas9 to each gRNA also resulted in substan-
tial lethality, with the few animals that progressed to adulthood
exhibiting a range of morphological defects consistent with
defects in Wg signaling (Fig. 3C). Unsurprisingly, many of these
adults died shortly after eclosion, and those that survived often
had poor fertility. In contrast, no significant lethality was ob-
served for nos-cas9 U6:3-gRNA-wg and nos-cas9 U6:3-gRNA-wls
pupae (Fig. 3B). All the eclosed adults appeared morphologically
normal, with the exception of 5% of nos-cas9 U6:3-gRNA-wls
flies that had small notches in the wing (Fig. 3C). This phenotype
indicates a local impairment of Wg signaling, suggesting that not
all Cas9 activity is restricted to the germ line when nos-cas9 is
combined with this gRNA. This series of experiments demonstrates
that only the nos-cas9 line has sufficiently germ-line–restricted
Cas9 activity to allow efficient development of flies to adulthood
when either essential gene is targeted.
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Fig. 3. Efficient targeting of essential genes. (A) Schematic of sequence and position of target sites of gRNA-wg and gRNA-wls. (B) Summary of fate of
animals that developed to pupal stage and that coexpressed U6:3-gRNA-wg or U6:3-gRNA-wls with different cas9 transgenes. (C) Representative examples of
phenotypes observed in adult cas9 gRNA-wg and cas9 gRNA-wls flies. Defects consistent with perturbed Wg signaling include wing notches (Upper) and
malformation of the legs and abdominal segments (Lower). Images at the left and center left show severe malformations; image on the top right shows mild
malformations. The arrowhead indicates a wing notch, which was found in 5% of nos-cas9 U6:3-gRNA-wls flies. (D) Summary of results assessing transmission
ofwg loss-of-function alleles (wgLOF) by genetic complementation tests with a knownwg null allele (in the four crosses, four of four flies, one of six flies, three
of five flies, and four of four flies inherited a wgLOF allele). wgCRISPR alleles that retain function are not detected by this method. (E) Assessment of trans-
mission of nonfunctional wls alleles. A fertile nos-cas9 gRNA-wls fly was crossed to a balancer stock, and the wls locus of 15 heterozygous progeny was
sequenced. Ten sequencing chromatograms could be read unambiguously; all contained indels at the target site. The mutated sequence is shown below the
wild-type sequence. The 27-bp deletion was recovered in two different flies.
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We next evaluated germ-line transmission of CRISPR/Cas-
induced mutations in wg and wls using nos-cas9. Nineteen ran-
domly selected offspring of nos-cas9 U6:3-gRNA-wg flies were
tested for wg mutations by genetic complementation with a pre-
viously characterized wg null allele (27). The wg null allele was
not complemented in 12 of the 19 crosses, demonstrating effi-
cient creation of nonfunctional wg mutations by CRISPR/Cas
(Fig. 3D).
The nos-cas9 U6:3-gRNA-wls females were poorly fertile,
which is compatible with the requirement for maternal Wls
during embryonic development (25, 26). The nos-cas9 U6:3-
gRNA-wls males also had low fertility, raising the possibility of
a previously undescribed role for Wls in the male germ line.
Nonetheless, we were able to sequence wls alleles from PCR
products of 15 randomly selected offspring of an outcrossed nos-
cas9 U6:3-gRNA-wls fly that was fertile. The sequencing chro-
matograms had double peaks around the gRNA target site in
every case. This pattern indicates the presence of a CRISPR/
Cas-induced wls mutant allele in each fly, along with the wild-
type allele inherited from the other parent. Peaks from the
mutagenized and wild-type wls alleles could be called un-
ambiguously in the sequencing traces from 10 of the 15 samples;
each of these 10 traces revealed an indel mutation, nine of which
were unique (Fig. 3E). Many of the indels created frameshifts or
removed the ATG start codon, presumably resulting in loss of wls
function. Together these results show that our optimized CRISPR/
Cas system allows the generation of loss-of-function alleles in
essential genes at frequencies that make screening with meth-
ods other than direct DNA sequencing unnecessary.
Precise Genome Modification by HDR. The work described above
identified tools for generating loss-of-function indel mutations in
both the soma and germ line of Drosophila. In many cases, it is
desirable to dissect gene function further by introducing specific
sequence changes into the genome. In Drosophila it has been
possible for several years to create specific genome modifications
by HDR, although targeting typically occurs with very low
efficiency (28). Recent studies have suggested that zinc finger,
transcriptional activator-like effector (TALE), and Cas9 nucleases
can increase the efficiency of HDR in flies, implying that the gen-
eration of site-specific DSBs is rate limiting (11, 12, 27, 29, 30).
Therefore we tested whether the highly effective creation of DSBs
by our transgenic CRISPR/Cas system could be exploited to facil-
itate efficient HDR.
We first attempted to introduce a missense mutation into the
wls locus using an ssDNA oligonucleotide donor (ssODN). We
designed an ssODN harboring a G-to-C transversion at the
gRNA-wls target site, which would cause a Gly11Ala mutation in
Wls and remove the PAM sequence (Fig. 4A). The ssODN was
injected into nos-cas9 U6:3-gRNA-wls preblastoderm embryos,
with six of the resulting flies outcrossed. Sequence analysis of the
wls locus from the offspring of these crosses revealed that four of
the six flies had transmitted the designed change, with 28% of
the 46 tested progeny receiving the mutation (Fig. 4 B and C).
Sixty-one percent of the total progeny instead inherited an indel
mutation at the target site, and the other animals received an
unmodified wls allele. We also introduced an 11-bp sequence
containing a restriction site into the e locus by ssODN injection
into act-cas9 U6:3-gRNA-e embryos; 11% of the 76 progeny an-
alyzed contained the desired mutation (Fig. S4). These data
demonstrate that our CRISPR/Cas tools can support HDR using
oligonucleotide-derived sequences with efficiencies compatible
with direct screening for targeting events by PCR and sequenc-
ing. We also injected a circular double-stranded plasmid con-
taining the GFP-coding sequence flanked by 1.4- and 1.7-kb
homology arms from the wg locus into nos-cas9 U6:3-gRNA-wg
embryos (Fig. S5A). The donor template is designed to produce
an in-frame insertion of GFP within the wg coding region, leading
to a secreted Wg::GFP protein. Thirty-eight percent of the off-
spring of injected embryos expressed a GFP protein in the Wg
expression pattern, which appeared to be secreted (Fig. S5 B–D).
PCR-based analysis of the wg locus in five of these animals con-
firmed successful ends-out targeting in all cases (Fig. S5E).
These data provide evidence that our CRISPR/Cas tools also
can be used to introduce longer exogenous sequences into an
essential gene with high efficiency.
CRISPR/Cas as a Tool for Analyzing Loss-of-Function Mutant Phenotypes
in Somatic Tissues.An important result from the evaluation of our
tools is that transgenic CRISPR/Cas with U6:3-gRNAs can result
in highly effective biallelic mutagenesis in the soma. We noticed
in our experiments targeting y and e that cuticles frequently
contained large patches of cells with the same mutant phenotype
(Fig. 1 B and C), presumably resulting from clonal inheritance of
the same CRISPR/Cas-induced lesion. Analysis of classical Dro-
sophila mutations in genetic mosaics has been invaluable for un-
derstanding functions of genes that act at multiple stages during
development as well as cell autonomous and nonautonomous
mechanisms (31). However, generating the stocks required to in-
duce clones by traditional methods is time consuming (Discus-
sion). Therefore we wondered if our CRISPR/Cas tools could be
used for the rapid generation of clones in which both alleles of
essential genes are mutated.
We first analyzed wing imaginal discs from act-cas9 U6:3-
gRNA-wls third-instar larvae using an antibody that recognizes
the C-terminal tail of the Wls protein (32). Endogenous Wls
is expressed ubiquitously in the wing imaginal disc, where it is
required for the secretion of the Wg signaling molecule from
Wg-producing cells (25, 26, 32). All wing imaginal discs from
control act-cas9 U6:3-gRNA-e animals had wild-type Wls protein
levels and distribution (Fig. 5A). In contrast, all act-cas9 U6:3-
gRNA-wls wing imaginal discs examined contained patches of
cells with partially reduced Wls levels, with no Wls protein,
or with wild-type Wls levels (Fig. 5B). The first two scenarios
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Fig. 4. Efficient incorporation of an exogenous sequence in wls by HDR
following Cas9-induced DSBs. (A) Schematic of the donor DNA in relation to
the gRNA target site at the wls locus. The donor was a single-stranded oli-
gonucleotide with 60-nt homology to the wls locus at either side of the Cas9
cut site and a G-to-C transversion (red, lowercase) that disrupts the PAM
sequence. Donor DNA was injected into embryos that were the progeny of
nos-cas9 females and U6:3-gRNA-wls males. (B) Summary of results from
screening flies for HDR events by PCR and sequencing. In the six crosses,
none of eight flies, two of eight flies, three of eight flies, six of seven flies,
none of seven flies, and two of eight flies inherited the wlsG32C allele. (C)
Example of the verification of the precise integration of the donor DNA in
the wls locus by direct sequencing of a PCR product amplified from a het-
erozygous fly. Double peaks in the chromatogram represent an overlay of
the sequence from the mutant and wild-type wls alleles. The asterisk indi-
cates the position of the mutation.
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presumably reflect clonal tissue that has one or two wls mutant
alleles, respectively, that fail to produce full-length Wls protein.
Wg protein was retained in Wg-producing cells within clones that
lacked detectable Wls protein (Fig. 5B), confirming biallelic
disruption of wls.
We next examined wing imaginal discs from act-cas9 U6:3-
gRNA-wg animals using an anti-Wg antibody (33). The Wg ex-
pression domain normally includes a stripe of cells along the
dorsal–ventral boundary of the wing pouch, a pattern always
observed in act-cas9 U6:3-gRNA-e discs (Fig. 5A). In contrast,
act-cas9 U6:3-gRNA-wg discs had disrupted patterns of Wg ex-
pression (Fig. 5C). Although clones that lost all detectable Wg
protein were common, presumably reflecting biallelic loss-of-
function mutations, we also observed clones with increased abun-
dance or altered subcellular distribution of the protein (Fig. 5C
and Fig. S6). These latter clones likely contain in-frame muta-
tions at the gRNA target site that confer new properties to the
Wg protein. This finding suggests that CRISPR/Cas also can
shed light on the functional roles of specific regions of a protein.
The experiments described above demonstrated that act-cas9
and U6:3-gRNA can be used in imaginal discs to induce biallelic
targeting of essential genes in a stochastic fashion. To investigate
whether our transgenic CRISPR/Cas tools can reveal somatic
mutant phenotypes at earlier developmental stages, we attempted
to disrupt wg function in the embryo. wg is expressed zygotically in
the embryo and is required for segment polarity; classical wg null
mutants fail to complete embryogenesis and have regions of naked
cuticle replaced with an array of denticles (24). Our earlier finding
that many act-cas9 U6:3-gRNA-wg embryos develop to pupal
stages demonstrates that they retain significant wg function
(Fig. 3B). We therefore generated a gRNA transgene that simul-
taneously expresses three gRNAs targeting the wg promoter
(gRNA-wgP1–3). This construct, in which the gRNAs were under
the control of the U6:1,U6:2, andU6:3 promoters, was integrated
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Fig. 5. Revealing mutant phenotypes through efficient biallelic targeting with transgenic CRISPR/Cas. (A–C) Genetic mosaics induced in third-instar wing
imaginal discs by somatic CRISPR/Cas. (A) Control act-cas9 U6:3-gRNA-e wing discs have ubiquitous expression of Wls and expression of Wg in a stripe along
the dorsal–ventral boundary. (B) act-cas9 U6:3-gRNA-wls discs have patches of cells with wild-type Wls levels, partially reduced Wls expression, and no de-
tectable Wls protein. Wg protein accumulates intracellularly in Wg-producing cells in the absence of Wls (bracket). (C) Clones with different distributions of
endogenous Wg protein can be observed in act-cas9 U6:3-gRNA-wg discs: 1, wild type; 2, nuclear accumulation; 3, increased Wg levels; and 4, no Wg protein.
A second example with abnormal nuclear Wg staining is shown at higher magnification in Fig. S6. Images are representative of >10 discs of each genotype.
(D–K) Biallelic targeting by transgenic CRISPR/Cas can reveal mutant phenotypes during embryogenesis. (D–F) Cuticle preparations at the end of embryo-
genesis. (D) act-cas9 U6:3-gRNA-e control animal. (E and F) All act-cas9 gRNA-wgP1–3 embryos (E) and most embryos from nos-cas9 U6:3-gRNA-wls parents (F)
have naked region of cuticle replaced by denticle bands (exemplified by arrowheads). (G–K) Analysis of Wg protein in stage 9/10 embryos by immunostaining
(“fire” lookup table facilitates comparison of Wg signal intensity in different genotypes). Compared with control nos-cas9 U6:3-gRNA-e embryos (G), Wg
signal is strongly reduced in act-cas9 gRNA-wgP1–3 embryos (H) and is strongly increased in embryos from nos-cas9 U6:3-gRNA-wls parents (I). (J and K) Higher-
magnification views of Wg protein in embryos, showing variation in levels in act-cas9 gRNA-wgP1–3 embryos (K), presumably caused by independent CRISPR/
Cas targeting events in subsets of cells. act-cas9 U6:3-gRNA-e is shown as a control (J). Images are representative of >50 embryos examined. (L and M) Cas9
activity can be focused on specific tissues by Gal4/UAS. Expression of gRNA-wls together with UAS-cas9 (line CFD5 in Table S1) under the control of enGal4 and
Gal80ts gives rise to viable flies that have wing notches posteriorly in the adult wing (M; arrowhead). Control wing (L) is from an animal that did not inherit
the gRNA-wls transgene. All genotypes in this figure refer to one copy of each transgene. (Scale bars: A–C, 40 μm; D–F, 100 μm; G–K, 30 μm.)
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at the attP2 site. All act-cas9 gRNA-wgP1–3 animals arrested before
the end of embryogenesis with a strong segment polarity phenotype
(Fig. 5D andE). This result presumably reflects biallelic disruption
ofwg expression, because a single functional copy ofwg is sufficient
for normal development. Indeed, immunostaining of act-cas9
gRNA-wgP1–3 embryos revealed strongly reduced expression of
Wg protein compared with act-cas9 U6:3-gRNA-e controls (Fig. 5
G,H, J, andK), indicative of interferencewith transcription of both
alleles. We conclude that somatic CRISPR/Cas can be used to
induce biallelic mutations in genes that are expressed zygotically
in embryos.
Additional observations indicated that transgenic CRISPR/
Cas also can be used to study loss-of-function embryonic phe-
notypes of maternally contributed genes. As described above,
nos-cas9 U6:3-gRNA-wls adults had low fertility. Closer inspec-
tion revealed that intercrosses of these flies resulted in many
eggs being laid but with less than 5% developing to larval stages.
Wls normally is contributed maternally to the embryo. Although
zygotic wls null mutants from heterozygous mothers develop
until pupal stages, offspring of mothers with a homozygous wls-
mutant germ line die at embryonic stages with cuticle phenotypes
typical of perturbed Wg signaling (25, 26). The great majority of
embryos from nos-cas9 U6:3-gRNA-wls mothers arrested at the
end of embryogenesis with segment polarity phenotypes remi-
niscent of wls germ-line mutant clones (Fig. 5F). This observa-
tion indicates biallelic disruption of wls in the germ line of
nos-cas9 U6:3-gRNA-wls females. Consistent with this notion,
immunostaining revealed a strong accumulation of Wg protein
within producing cells of embryos derived from nos-cas9 U6:3-
gRNA-wls mothers (Fig. 5I), presumably resulting from defective
Wg protein secretion in the absence of Wls.
Finally, we explored whether biallelic gene targeting in specific
somatic cell types was possible by coupling CRISPR/Cas to the
Gal4/UAS system. UAS-cas9 was combined with engrailed-Gal4
(enGal4), which drives UAS expression specifically in posterior
compartments of the animal, and gRNA-wls. We also included
a temperature-sensitive Gal80 transgene (Gal80ts) to restrict
Cas9 activity further by temporal control of Gal4. Following a
temperature shift of second-instar larvae of this genotype to 29 °C,
many adult flies had pronounced notches specifically in the
posterior half of the wing (Fig. 5 L and M). This phenotype was
not observed in the absence of gRNA-wls (Fig. 5L). These results
show that biallelic targeting of essential genes can be focused
on specific cell types by regulating expression of Cas9 with Gal4/
UAS. However, the first generation of UAS-cas9 constructs
requires optimization. Substantial lethality was observed when
UAS-cas9 transgenic lines were crossed to strong, ubiquitous
Gal4 drivers, and this lethality was not dependent on the pres-
ence of a gRNA. This toxicity also was not dependent on the
endonuclease activity of Cas9, because it also was observed with
a catalytically dead mutant protein. Furthermore, when UAS-
cas9 was combined with gRNA-wls, we observed some wls− clones
in wing discs that were independent of Gal4 activity. Nonetheless
this effect, which presumably is caused by leaky expression from
the UAS promoter, was not sufficient to produce wing notching
in the adult. Future efforts will be aimed at producing UAS-cas9
variants that have reduced expression levels but still retain suf-
ficient activity for biallelic targeting in response to Gal4.
Discussion
CRISPR/Cas promises to revolutionize genome engineering in
a large variety of organisms. Although proof-of-principle studies
have demonstrated CRISPR/Cas-mediated mutagenesis in
Drosophila melanogaster (5–12), a systematic evaluation of dif-
ferent tools has not been reported. We have developed a collec-
tion of tools to harness further the potential of CRISPR/Cas for
functional studies in Drosophila. We have characterized different
Cas9 and gRNAs expression constructs and revealed combinations
that allow mutagenesis of essential and nonessential genes
with high rates, support efficient integration of exogenous
sequences, and can reveal mutant phenotypes readily in somatic
tissues.
To assess the activity of different constructs, we used a fully
transgenic CRISPR/Cas system in which Cas9 and gRNA are
expressed from plasmid sequences stably integrated at defined
positions in the genome. The advantage of this approach for
comparative analysis is the low variability between experiments.
For example, we found that 100% of flies expressing transgenic
Cas9 and gRNA constructs had efficient germ-line mutagenesis
of the target site. In contrast, the number of animals that transmit
mutations to the next generation using delivery of one or both
CRISPR/Cas components by RNA or DNA microinjection is
highly variable and often is less than 50% (5, 6, 9–11). However,
injection-based CRISPR/Cas may be advantageous under certain
circumstances, such as when one wishes to generate a mutation
directly in a complex genetic background. Our gRNA-expression
plasmids are also suitable for this purpose.
Our quantitative analysis using transgenic Cas9 and gRNA
constructs reveals that, of the three U6 promoters, the previously
uncharacterized U6:3 promoter leads to the strongest gRNA
activity. This observation suggests that targeting rates of previous
approaches have been limited by the selection of the U6:2
or U6:1 promoter. In combination with highly active Cas9 lines
(e.g., act-cas9, vasa-cas9), transgenic U6:3-gRNA can be used to
transmit mutations in nonessential genes through the germ line
with remarkably high efficiency (i.e., with 50–100% of offspring
receiving a nonfunctional CRISPR-generated allele). However,
these Cas9 lines also are active outside the germ line, and biallelic
targeting in the soma effectively prevents their use for trans-
mission of mutations in essential genes in combination with
U6:3-gRNA transgenes. The ubiquitous activity of vasa-cas9 pre-
sumably was masked in a previous study in which a U6:2-gRNA
plasmid targeting the eye pigmentation gene rosy was injected at
the posterior of the embryo, thereby restricting its activity in the
vicinity of the future germ cells (11). It remains to be evaluated if
activity of CRISPR/Cas is sufficiently restricted by this approach
to allow efficient germ-line transmission of mutations in essential
genes. We demonstrate that efficient targeting of essential genes
is possible using U6:3-gRNA transgenes in combination with the
transgenic nos-cas9 line in which endonuclease activity is largely
germ-line restricted. This finding held true even for wls, which is
required in the germ line, because fertility (although much re-
duced) was not abolished.
Our optimized CRISPR/Cas system also allowed the inte-
gration of designer mutations with high efficiency. By injecting
oligonucleotide donors and donor plasmids into embryos ex-
pressing cas9 and gRNA transgenes, we achieved precise modi-
fication of the target site in 11–38% of all offspring analyzed. A
previous study in which an oligonucleotide was injected together
with cas9 and gRNA plasmids found that 0.3% of all offspring
integrated the exogenous sequence at the target site (5). Very
recently, Gratz et al. (11) have reported integration rates for
larger constructs that range from 0–11% by injecting the donor
and gRNA plasmid into vasa-cas9 transgenic embryos. It is dif-
ficult to compare the integration efficiency of our method with
that in previous studies directly because of the use of different
gRNAs, donors, and target genes. Nonetheless, the increased
reproducibility and efficiency of site-specific DSB generation
with our optimized, fully transgenic CRISPR/Cas system is likely
to facilitate integration of exogenous sequences by HDR as com-
pared with methods that deliver Cas9 or gRNA by direct embryo
injection. The frequency of integration is of paramount impor-
tance when the goal is to introduce subtle changes in the DNA
sequence, such as individual point mutations, because a low rate
of integration necessitates screening by cointegration of a marker
gene, which can affect function of the targeted locus [note that
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exogenous sequences are still retained following removal of
markers by site-specific recombinases (34)]. We demonstrate
here that optimized transgenic CRISPR/Cas can facilitate the
introduction of precise changes at endogenous loci with rates
that make it practical to screen solely by PCR and Sanger se-
quencing. We envisage that one important application of our
tools will be the introduction of disease mutations into the Dro-
sophila genome to model human pathologies.
We also demonstrate a novel application of CRISPR/Cas in
rapidly analyzing gene function in somatic cells. Our optimized
tools permit efficient generation of genetic mosaics in which
clones of cells have biallelic gene disruption. Mitotic recombina-
tion using the yeast site-specific recombinase Flp is typically used
for this purpose in Drosophila (34). This method requires recom-
bination of the mutation of interest onto a chromosome contain-
ing the FLP recombinase target (FRT) site; this process is time
consuming, particularly for genes located close to the FRT site.
Somatic CRISPR/Cas requires only one cross to give rise to
mosaics. Furthermore, unlike the FRT/Flp system, there is no
a priori reason for CRISPR/Cas to require cell division, and
hence this method should be better suited for interrogating gene
function in differentiated tissues such as the adult brain. One
advantage of FRT/Flp in mosaic analysis is that clones can be
marked readily by the presence or absence of a linked marker
gene, such as gfp. Here we identified mutant cells with antibodies
specific to the proteins studied, but for many proteins no anti-
body will be available. Under these circumstances we envisage
mutant tissue being identified first by using CRISPR/Cas to gen-
erate a line in which a fluorescent protein or short epitope tag
has been knocked into the endogenous locus. In any case, such
a reagent would be valuable for characterizing the function of
the protein. We anticipate that CRISPR/Cas and FRT-Flp will
coexist as complementary methods for mosaic analysis of gene
function in the future.
As is the case for somatic CRISPR/Cas, RNAi can reveal
mutant phenotypes after a single cross. However, RNAi often
reduces gene expression only partially, meaning that some mutant
phenotypes can be incompletely penetrant or missed all together
because of residual protein. Somatic CRISPR/Cas readily provides
access to null-mutant phenotypes caused by biallelic out-of-frame
mutations. Consequently, somatic targeting of all genes tested
(e, y, cu, wg, or wls) revealed the classical loss-of-function mutant
phenotype with high penetrance. Furthermore, RNAi is notorious
for off-target effects (35), which can complicate phenotypic anal-
ysis significantly. Early studies in human cells did suggest that off-
target mutagenesis also is prevalent for CRISPR/Cas (36, 37).
However, experiments in Drosophila so far have failed to detect
induced mutations at sites without perfect complementarity
(6, 11). These findings suggest that CRISPR/Cas operates with
high fidelity in flies, although addressing the issue of specificity
definitively will require genome-wide searches for induced indels.
Nonetheless, it is encouraging that nonspecific phenotypes were
not detected in any of our experiments targeting e, y, cu, wg, or wls.
A recent study showed that truncating the target sequence of
gRNAs results in improved fidelity of CRISPR/Cas in human cells
(38), suggesting a straightforward approach to minimize the risk of
off-target effects in Drosophila. Our generation of tools for offset
nicking-based mutagenesis in flies provides a further option for
increasing specificity. Because of the ease with which CRISPR/Cas
experiments can be performed, the specificity of mutant pheno-
types generated with wild-type Cas9 also can be tested using
multiple independent gRNAs.
High-throughput genetic screens are likely to be another im-
portant application of somatic gene targeting by CRISPR/Cas.
The generation of gRNA-expression plasmids through cloning
of annealed short oligonucleotides is an easy and economic
one-step process that is scalable to generate a library of targeting
vectors for thousands of genes. CRISPR/Cas-based screens will
be particularly powerful if mutagenesis can be restricted in time
and space. We have taken a step in this direction by demon-
strating that expressing Cas9 under the control of the Gal4/UAS
system can enrich biallelic targeting within a defined group of cells.
Materials and Methods
Addition materials and methods are described in SI Materials and Methods.
Plasmid Construction. Unless otherwise noted, cloning was performed with
the Gibson Assembly Master Mix (New England Biolabs). PCR products were
produced with the Q5 High-Fidelity 2×Master Mix (New England Biolabs). All
inserts were verified by sequencing. Details of plasmid construction are
available in SI Materials and Methods. Primers used for plasmid construction
are listed in Table S5.
Drosophila Genetics. Details of transgenes and fly stocks are given in Tables
S1–S3 and S6. Throughout this study, transgenic cas9 virgin females were
crossed to U6-gRNA–expressing males.
Assessing relative activity of Cas9 and gRNA lines. All crosses involving gRNA-e
produced offspring with two wild-type e alleles that can be subjected to
gene targeting by CRISPR/Cas. Because some Cas9 strains were generated in
a y mutant background and some attP sites are marked by y+ transgenes,
offspring from the different gRNA-y crosses inherit different numbers of y
alleles from their parents (Fig. 1C and Table S3). As a result, either 0% or
25% of F2 offspring from the different crosses would be expected to be
phenotypically yellow in the absence of CRISPR/Cas-mediated mutagenesis.
To correct for this imbalance, we subtracted 25% of the phenotypically
yellow animals when calculating germ-line transmission rates of nonfunc-
tional alleles from data collected from the latter type of cross.
Genetic complementation of wg loss-of-function alleles. nos-cas9/+; gRNA-wg/+
flies were crossed to a Sp/CyO balancer strain. Individual flies of the geno-
type wgtest/CyO then were crossed to wgTV-Cherry/CyO flies. wgTV-Cherry is a
wg null allele in which the first exon of wg is replaced with a homologous
recombination targeting cassette (27). The next generation of the crosses
was screened for the presence or absence of flies without the CyO chro-
mosome. Cultures in which all flies had the CyO chromosome indicated that
the wgtest allele could not genetically complement wgTV-Cherry and hence did
not encode functional Wg protein.
Molecular Characterization of Target Loci. To identify the molecular nature of
CRISPR/Cas-induced mutations, genomic DNA was extracted from individual
flies or larvae by crushing them in 15 μL microLysis-plus (Microzone) and
releasing the DNA in a thermocycler according to the supplier’s instructions.
We used 0.5 μL of the supernatant in 25-μL PCR reactions (Q5 2×Master Mix
kit; New England Biolabs) using primers binding 300–500 bp upstream and
downstream of the target site. PCR products were gel purified and were
either sent directly for Sanger sequencing or cloned into pBluescript-SK(+)
by Gibson assembly. In the latter case, single colonies were selected as
templates for PCR amplification, and PCR products were sequenced. Direct
sequencing of PCR products from genomic DNA of heterozygous flies usually
yields an overlay of the DNA sequence from both chromosomes. Indels can
be observed as regions with double peaks in the trace. In the majority of
such regions the sequence of both alleles can be called unambiguously (see
Fig. 4C and Fig. S4D for examples).
Embryo Injections. Embryos were injected using standard procedures (further
details are given in SI Materials and Methods). For the delivery of plasmid
DNA for the production of transgenes with the Phi31C system, 150 ng/μL of
DNA in sterile dH2O was injected. ssODNs designed to modify the wls locus
were injected into the posterior region of nos-cas9/+; U6-3-gRNA-wls/+
preblastoderm embryos as a 750-ng/μL solution in dH2O.
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